News coverage about Transcat (NASDAQ:TRNS) has trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Transcat earned a news sentiment score of 0.10 on Accern’s scale. Accern also assigned news stories about the scientific and technical instruments company an impact score of 45.6116866587066 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
A number of research analysts recently issued reports on the company. Singular Research increased their price objective on Transcat from $15.30 to $20.00 and gave the stock a “buy” rating in a report on Monday, February 5th. Zacks Investment Research upgraded Transcat from a “hold” rating to a “buy” rating and set a $18.00 price objective for the company in a report on Wednesday, February 14th. Roth Capital assumed coverage on Transcat in a report on Friday, February 9th. They set a “buy” rating and a $20.00 price objective for the company. Finally, ValuEngine upgraded Transcat from a “hold” rating to a “buy” rating in a report on Wednesday, April 11th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $19.25.
Shares of NASDAQ:TRNS traded up $0.43 during mid-day trading on Monday, reaching $17.08. 600 shares of the stock were exchanged, compared to its average volume of 11,818. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.38 and a current ratio of 1.98. The company has a market cap of $122.13, a PE ratio of 26.69, a PEG ratio of 2.36 and a beta of 0.42. Transcat has a one year low of $11.60 and a one year high of $17.08.
Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.21 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.09. Transcat had a return on equity of 10.03% and a net margin of 3.24%. The business had revenue of $40.48 million during the quarter. research analysts predict that Transcat will post 0.7 earnings per share for the current fiscal year.
In related news, Director John T. Smith sold 2,000 shares of the stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $15.70, for a total transaction of $31,400.00. Following the completion of the transaction, the director now directly owns 33,100 shares of the company’s stock, valued at $519,670. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 8.80% of the company’s stock.
Transcat Company Profile
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services.
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.